pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

ADA admits unclear policies after ejecting members, sparks boycott and journal shutdown

Oct 23, 2026·read at STAT ↗Negative

The American Diabetes Association ejected five members from a scientific session in New Orleans on June 5 and later issued two explanations, an apology and a summary of its internal review. The organization said a written threat of protest and disruption had prompted the removals, but also acknowledged that its code of conduct did not clearly address the distribution of materials inside the convention.

The ejections have triggered a backlash from members, including a petition and an estimated 1,100‑member boycott. In response, the ADA’s flagship journal has halted manuscript submissions and grant reviews, and the group has suspended fundraisers and educational activities.

On Friday the ADA posted a new news release outlining a longer‑term review of the incident, three days after the unexplained departure of Rita Kalyani, its chief medical and scientific officer. The release reiterated concerns about potential disruption while conceding that its policies were ambiguous, and it promised further examination of the matter.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Diabetes association says ‘threat’ preceded members’ ejections, but admits policies were unclear”

read at STAT ↗
483 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2BRISTOLBRISTOL MYERS SQUIBBBRISTOL MYERS SQUIBB CONOVARTIS
topics
Type 2 Diabetes7Cardiology4Endocrinology & Metabolism2Oncology2CAR-TImmunologyMelanomaMultiple SclerosisVaccine

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • 7h agoTango plans 14% workforce cut, mainly of research staffBioSpace
  • 3h agoSTAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived earlySTAT
  • Oct 9Hengrui has become the go-to source of China biopharma innovation. What’s its secret?Fierce Biotech